An improved coverage and spatial resolutiona-using dual injection dynamic contrast-enhanced (ICE-DICE) MRI: A novel dynamic contrast-enhanced technique for cerebral tumors

Magnetic Resonance in Medicine

Volumn 68, Issue 2, 2012, Pages 452-462

  Li, Ka Loh ^a   Buonaccorsi, Giovanni ^a   Thompson, Gerard ^a   Cain, John R ^a   Watkins, Amy ^a   Russell, David ^a   Qureshi, Salman ^b   Evans, D Gareth ^c   Lloyd, Simon K ^b,d   Zhu, Xiaoping ^a   Jackson, Alan ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

brain tumor; dual temporal resolution dynamic contrast enhanced MRI; perfusion and permeability

Indexed keywords

MAGNETIC RESONANCE IMAGING; MAPPING; PHARMACOKINETICS; TUMORS;

ACQUISITION PROTOCOLS; ARTERIAL INPUT FUNCTION; BRAIN TUMORS; DYNAMIC CONTRAST ENHANCED; DYNAMIC CONTRAST ENHANCED MRI; HIGH SPATIAL RESOLUTION; HIGH TEMPORAL RESOLUTION; PLASMA CONCENTRATION;

IMAGE RESOLUTION;

BEVACIZUMAB;

ACCURACY; ACOUSTIC NEURINOMA; ADULT; AGED; ANALYTICAL ERROR; ARTICLE; BOLUS INJECTION; BRAIN CANCER; BRAIN DAMAGE; BRAIN MAPPING; BRAIN TISSUE; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MALE; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MONTE CARLO METHOD; NEUROFIBROMATOSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL NOISE RATIO; THREE DIMENSIONAL IMAGING;

EID: 84863829006     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.23252     Document Type: Article

References (38)

1. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM,. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232. (Pubitemid 29463104)
2. Tofts PS,. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7: 91-101. (Pubitemid 28365643)
3. Fritz-Hansen T, Rostrup E, Sondergaard L, Ring PB, Amtorp O, Larsson HB,. Capillary transfer constant of Gd-DTPA in the myocardium at rest and during vasodilation assessed by MRI. Magn Reson Med 1998; 40: 922-929. (Pubitemid 28543845)
4. Henderson E, Rutt BK, Lee TY,. Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging 1998; 16: 1057-1073. (Pubitemid 29196842)
5. Christian TF, Rettmann DW, Aletras AH, Liao SL, Taylor JL, Balaban RS, Arai AE,. Absolute myocardial perfusion in canines measured by using dual-bolus first-pass MR imaging. Radiology 2004; 232: 677-684. (Pubitemid 39100248)
6. Kostler H, Ritter C, Lipp M, Beer M, Hahn D, Sandstede J,. Prebolus quantitative MR heart perfusion imaging. Magn Reson Med 2004; 52: 296-299. (Pubitemid 39025273)
7. Risse F, Semmler W, Kauczor HU, Fink C,. Dual-bolus approach to quantitative measurement of pulmonary perfusion by contrast-enhanced MRI. J Magn Reson Imaging 2006; 24: 1284-1290. (Pubitemid 44871872)
8. Makkat S, Luypaert R, Sourbron S, Stadnik T, De Mey J,. Assessment of tumor blood flow in breast tumors with T1-dynamic contrast-enhanced MR imaging: impact of dose reduction and the use of a prebolus technique on diagnostic efficacy. J Magn Reson Imaging 2010; 31: 556-561.
9. Press W, Teukolsky S, Vetterling W, Flannery B,. Numerical recipes in C, the art of scientific computing. New York: Cambridge University Press; 1992. pp 112-119.
10. Horsfield MA, Thornton JS, Gill A, Jager HR, Priest AN, Morgan B,. A functional form for injected MRI Gd-chelate contrast agent concentration incorporating recirculation, extravasation and excretion. Phys Med Biol 2009; 54: 2933-2949.
11. Zhu XP, Li KL, Kamaly-Asl ID, Checkley DR, Tessier JJ, Waterton JC, Jackson A,. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. J Magn Reson Imaging 2000; 11: 575-585. (Pubitemid 30350299)
12. Cheong LH, Koh TS, Hou Z,. An automatic approach for estimating bolus arrival time in dynamic contrast MRI using piecewise continuous regression models. Phys Med Biol 2003; 48: N83-N88. (Pubitemid 36335902)
13. Canet E, Douek P, Janier M, Bendid K, Amaya J, Millet P, Revel D,. Influence of bolus volume and dose of gadolinium chelate for first-pass myocardial perfusion MR imaging studies. J Magn Reson Imaging 1995; 5: 411-415.
14. Makkat S, Luypaert R, Sourbron S, Stadnik T, De Mey J,. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data. J Magn Reson Imaging 2007; 25: 1159-1167. (Pubitemid 46870273)
15. Press W, Teukolsky S, Vetterling W, Flannery B,. Numerical recipes in C, the art of scientific computing. New York: Cambridge University Press; 1992. pp 305-309.
16. Li KL, Zhu XP, Jackson A,. Parametric mapping of scaled fitting error in dynamic susceptibility contrast enhanced MR perfusion imaging. Br J Radiol 2000; 73: 470-481. (Pubitemid 30311487)
17. Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E,. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 2009; 361: 358-367.
18. Jackson A, Jayson GC, Li KL, Zhu XP, Checkley DR, Tessier JJ, Waterton JC,. Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma. Br J Radiol 2003; 76: 153-162. (Pubitemid 36553239)
19. Gowland P, Mansfield P, Bullock P, Stehling M, Worthington B, Firth J,. Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging. Magn Reson Med 1992; 26: 241-258.
20. Li KL, Zhu XP, Waterton J, Jackson A,. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 2000; 12: 347-357. (Pubitemid 30612881)
21. Ewing JR, Knight RA, Nagaraja TN, Yee JS, Nagesh V, Whitton PA, Li L, Fenstermacher JD,. Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of 14C-sucrose in areas of blood-brain opening. Magn Reson Med 2003; 50: 283-292. (Pubitemid 36950847)
22. Foottit C, Cron GO, Hogan MJ, Nguyen TB, Cameron I,. Determination of the venous output function from MR signal phase: feasibility for quantitative DCE-MRI in human brain. Magn Reson Med 2010; 63: 772-781.
23. Iannotti F, Fieschi C, Alfano B, Picozzi P, Mansi L, Pozzilli C, Punzo A, Del Vecchio G, Lenzi GL, Salvatore M,. Simplified, noninvasive PET measurement of blood-brain barrier permeability. Journal of computer assisted tomography 1987; 11 (3): 390-397. (Pubitemid 17081502)
24. Iannotti F, Fieschi C, Alfano B, Picozzi P, Mansi L, Pozzilli C, Punzo A, Del Vecchio G, Lenzi GL, Salvatore M, et al. Simplified, noninvasive PET measurement of blood-brain barrier permeability. J Comput Assist Tomogr 1987; 11: 390-397. (Pubitemid 17081502)
25. Howles GP, Bing KF, Qi Y, Rosenzweig SJ, Nightingale KR, Johnson GA,. Contrast-enhanced in vivo magnetic resonance microscopy of the mouse brain enabled by noninvasive opening of the blood-brain barrier with ultrasound. Magn Reson Med 2010; 64: 995-1004.
26. Liu G, Rugo HS, Wilding G, McShane TM, Evelhoch JL, Ng C, Jackson E, Kelcz F, Yeh BM, Lee FT Jr, Charnsangavej C, Park JW, Ashton EA, Steinfeldt HM, Pithavala YK, Reich SD, Herbst RS,. Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. J Clin Oncol 2005; 23: 5464-5473.
27. Mills SJ, Patankar TA, Haroon HA, Baleriaux D, Swindell R, Jackson A,. Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol 2006; 27: 853-858. (Pubitemid 44897736)
28. Patankar TF, Haroon HA, Mills SJ, Baleriaux D, Buckley DL, Parker GJ, Jackson A,. Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas? AJNR Am J Neuroradiol 2005; 26: 2455-2465.
29. Roberts C, Issa B, Stone A, Jackson A, Waterton JC, Parker GJ,. Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies. J Magn Reson Imaging 2006; 23: 554-563.
30. Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW,. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005; 91: 1-10. (Pubitemid 40684933)
31. Li X, Springer CS Jr, Jerosch-Herold M,. First-pass dynamic contrast-enhanced MRI with extravasating contrast reagent: evidence for human myocardial capillary recruitment in adenosine-induced hyperemia. NMR Biomed 2009; 22: 148-157.
32. Jackson A, Haroon H, Zhu XP, Li KL, Thacker NA, Jayson G,. Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model. NMR Biomed 2002; 15: 164-173. (Pubitemid 34213406)
33. Meng R, Chang SD, Jones EC, Goldenberg SL, Kozlowski P,. Comparison between population average and experimentally measured arterial input function in predicting biopsy results in prostate cancer. Acad Radiol 2010; 17: 520-525.
34. Donaldson SB, West CM, Davidson SE, Carrington BM, Hutchison G, Jones AP, Sourbron SP, Buckley DL,. A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix. Magn Reson Med 2010; 63: 691-700.
35. Jackson A, O'Connor JP, Parker GJ, Jayson GC,. Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clin Cancer Res 2007; 13: 3449-3459. (Pubitemid 46955104)
36. Stevenson JP, Rosen M, Sun W, Gallagher M, Haller DG, Vaughn D, Giantonio B, Zimmer R, Petros WP, Stratford M, Chaplin D, Young SL, Schnall M, O'Dwyer PJ,. Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. J Clin Oncol 2003; 21: 4428-4438. (Pubitemid 46621821)
37. Lopata RG, Backes WH, van den Bosch PP, van Riel NA,. On the identifiability of pharmacokinetic parameters in dynamic contrast-enhanced imaging. Magn Reson Med 2007; 58: 425-429. (Pubitemid 47267663)
38. Schlemmer HP, Merkle J, Grobholz R, Jaeger T, Michel MS, Werner A, Rabe J, van Kaick G,. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol 2004; 14: 309-317. (Pubitemid 38181089)